GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

New Horizon Health (HKSE:06606) Total Revenue Growth Rate (Future 3Y To 5Y Est) : N/A (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, New Horizon Health's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.


Competitive Comparison of New Horizon Health's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Medical Devices subindustry, New Horizon Health's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Horizon Health's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where New Horizon Health's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.



New Horizon Health  (HKSE:06606) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


New Horizon Health Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of New Horizon Health's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.


New Horizon Health (HKSE:06606) Business Description

Industry
Traded in Other Exchanges
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Executives
Invesco Advisers, Inc. 2102 Investment manager
Chen Yiyou 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Bancasa Holding Limited 2201 Interest of corporation controlled by you
Mst Development Limited 2101 Beneficial owner
Yao Naxin 2305 Beneficiary of a trust
Janus Henderson Group Plc 2102 Investment manager
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Invesco Developing Markets Fund 2106 Person having a security interest in shares
Zhu Yeqing 2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines